GH1 and pseudotumor cerebri: Additionally, given that nearly 70% of PHP1A patients develop GH deficiency [4, 9, 17, 18] and are treated with GH, it is important to distinguish headache caused by pseudotumor cerebri, a potential rare side effect of GH therapy, from headache caused by CM1.